One of the major highlights of the Muscular Dystrophy Association (MDA) Clinical & Scientific Conference is that invaluable networking opportunities can help clinicians elevate their own best practices.
Sharon Hesterlee, PhD
Advertisement
Articles by Sharon Hesterlee, PhD
Look ahead to this year's Muscular Dystrophy Association (MDA) meeting, which will feature discussions on the latest gene therapies, clinical trial data, policy considerations, and more in the realm of neuromuscular disease.
Advertisement
Latest Updated Articles
Advances in Gene Therapy, Neuroregeneration at the Forefront of MDA 2025Published: March 13th 2025 | Updated:
Building Community and Advancing Care at MDA 2025Published: March 24th 2025 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Real-World Data Support Dual Benefit of Biologic Therapy for Hidradenitis Suppurativa
2
Dual JAK Inhibition Demonstrates Efficacy in Progressive Nonsegmental Vitiligo
3
ERS Posters Showcase Nerandomilast Benefits in IPF, ILD
4
First-in-Class Rocatinlimab Aims to Rebalance T Cells in Atopic Dermatitis: Emma Guttman, MD, PhD
5
